Form 8K Ensysce Biosciences Inc For: 13 August
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ensysce Biosciences Inc (ENSC)
Track today's live Ensysce Biosciences (ENSC) share price, performance and key data on this page with our current NASDAQ:ENSC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Ensysce Biosciences share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ENSC share price, head to our technical summary section, which provides analysis on Ensysce Biosciences share price buy/sell indicators using real-time data (or discuss the Ensysce Biosciences (ENSC) stock price today with other investors in the Ensysce Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ENSC share price (ISIN: US2936025046) to enhance your trading decisions with our free investment tools and resources.
What Is the Ensysce Biosciences Inc Share Price Today?
The Ensysce Biosciences share price today is 0.3999.
What Is the Stock Symbol for Ensysce Biosciences Inc
The stock symbol (or 'ticker') for Ensysce Biosciences Inc is "ENSC."
What Stock Exchange Does Ensysce Biosciences Inc Trade On?
Ensysce Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Ensysce Biosciences Inc a Good Stock to Buy?
Determining whether Ensysce Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ENSC share price (ISIN: US2936025046) to enhance your trading decisions with our free investment tools and resources.
What Is the Ensysce Biosciences Inc Share Price Today?
The Ensysce Biosciences share price today is 0.3999.
What Is the Stock Symbol for Ensysce Biosciences Inc
The stock symbol (or 'ticker') for Ensysce Biosciences Inc is "ENSC."
What Stock Exchange Does Ensysce Biosciences Inc Trade On?
Ensysce Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Ensysce Biosciences Inc a Good Stock to Buy?
Determining whether Ensysce Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3306
0.4745
52 wk Range
0.2300
2.7500
Unusual Post-Market activity
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.33060.4745
52 wk Range
0.23002.7500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ENSC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Why is Ensysce Biosciences stock surging today?- Investing.com
Form 8K Ensysce Biosciences Inc For: 6 August- Investing.com
Form 8K Ensysce Biosciences Inc For: 6 August- Investing.com
- Form 8K Ensysce Biosciences Inc For: 13 August
- Investing.com
- Form 8K Ensysce Biosciences Inc For: 6 August
- Investing.com
- Form 8K Ensysce Biosciences Inc For: 6 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Earnings
Latest Release
18/05/2026
EPS / Forecast
-0.52 / -0.82
Revenue / Forecast
1M / --
Compare ENSC to Peers and Sector
Metrics to compare | ENSC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENSCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −1.6x | −0.4x | |
PEG Ratio | −0.01 | −0.05 | 0.00 | |
Price/Book | −7.5x | 1.5x | 2.6x | |
Price / LTM Sales | 1.3x | 9.9x | 3.1x | |
Upside (Analyst Target) | - | 198.0% | 47.8% | |
Fair Value Upside | Unlock | 15.4% | 6.2% | Unlock |
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company’s lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat opioid use disorder. Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ensysce Biosciences (NASDAQ: ENSC) Share Price Today?
The Ensysce Biosciences stock price today is 0.3999 USD.
What Stock Exchange Does Ensysce Biosciences (ENSC) Trade On?
Ensysce Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Ensysce Biosciences?
The stock symbol (also called a 'ticker') for Ensysce Biosciences is "ENSC."
What Is the Current Ensysce Biosciences Market Capitalisation?
As of today, Ensysce Biosciences (NASDAQ: ENSC) market cap is 5.1200M USD.
What Is Ensysce Biosciences's (ENSC) Earnings Per Share (TTM)?
The Ensysce Biosciences EPS is currently -3.0091 (Trailing Twelve Months).
When Is the Next Ensysce Biosciences Earnings Date?
Ensysce Biosciences's next earnings report will be released on 19/08/2026.
Is ENSC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Ensysce Biosciences moving averages and other technical indicators, the daily buy/sell signal for ENSC stock is Buy.
How Many Times Has Ensysce Biosciences Stock Split?
Ensysce Biosciences has split 3 times. (See the ENSC stock split history page for full effective split date and price information.)
How Many Employees Does Ensysce Biosciences Have?
Ensysce Biosciences has 9 employees, based on their latest Companies House report.
What is the current trading status of Ensysce Biosciences (NASDAQ: ENSC)?
As of 15/08/2026, Ensysce Biosciences (ENSC) is trading at a share price of 0.3999 USD, with a previous close of 0.3485 USD. The stock has fluctuated within a day range of 0.3306 USD to 0.4745 USD, while its 52-week range spans from 0.2300 USD to 2.7500 USD.
What Is Ensysce Biosciences (ENSC) Price Target According to Analysts?
The average 12-month price target for Ensysce Biosciences is 8.2500 USD, with a high estimate of 8.25 USD and a low estimate of 8.25 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,963.02% Upside potential.
What Is the ENSC Premarket Price?
ENSC's last pre-market stock price is 0.3427 USD. The pre-market share volume is 188,040.0000, and the stock has decreased by -0.0058, or -1.6600%.
What Is the ENSC After Hours Price?
ENSC's last after hours stock price is 0.3540 USD, the stock has decreased by -0.0459, or -11.4800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.